# Monitoring Milestones and Use of Funds in Corporate Venture Capital: Evidence for Investment and Governance | KEZ$

Canonical: https://kezs.com.br/en/learn/corporate-venture-capital-diligence/monitoring-milestones-and-use-of-funds-in-corporate-venture-capital-evidence-for-investment-and-governance
Language: en-US

How corporate venture capital investors can assess milestones, spending and pilots through evidence, clear governance and commercial independence.

[Corporate Venture Capital: diligence and governance](https://kezs.com.br/en/learn/corporate-venture-capital-diligence)

# Monitoring Milestones and Use of Funds in Corporate Venture Capital: Evidence for Investment and Governance

How corporate venture capital investors can assess milestones, spending and pilots through evidence, clear governance and commercial independence.

KEZS team · Educational guide

[Corporate Venture Capital](https://kezs.com.br/en/learn?tag=Corporate%20Venture%20Capital)[Investment Governance](https://kezs.com.br/en/learn?tag=Investment%20Governance)[Milestone Monitoring](https://kezs.com.br/en/learn?tag=Milestone%20Monitoring)[Use of Funds](https://kezs.com.br/en/learn?tag=Use%20of%20Funds)[Internal Sponsorship](https://kezs.com.br/en/learn?tag=Internal%20Sponsorship)[Intellectual Property](https://kezs.com.br/en/learn?tag=Intellectual%20Property)[Commercial Independence](https://kezs.com.br/en/learn?tag=Commercial%20Independence)

[← Corporate Venture Capital: diligence and governance](https://kezs.com.br/en/learn/corporate-venture-capital-diligence)[1. Monitor to make decisions, not simply to receive reports](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/monitoring-milestones-and-use-of-funds-in-corporate-venture-capital-evidence-for-investment-and-governance#topic-1)[2. Separate the financial investment thesis from the strategic hypothesis](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/monitoring-milestones-and-use-of-funds-in-corporate-venture-capital-evidence-for-investment-and-governance#topic-2)[3. Give internal sponsorship verifiable responsibilities](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/monitoring-milestones-and-use-of-funds-in-corporate-venture-capital-evidence-for-investment-and-governance#topic-3)[4. Define milestones with acceptance criteria and consequences](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/monitoring-milestones-and-use-of-funds-in-corporate-venture-capital-evidence-for-investment-and-governance#topic-4)[5. Turn the budget into a map of learning and cash](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/monitoring-milestones-and-use-of-funds-in-corporate-venture-capital-evidence-for-investment-and-governance#topic-5)[6. A numerical example: keep equity, the pilot and the budget separate](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/monitoring-milestones-and-use-of-funds-in-corporate-venture-capital-evidence-for-investment-and-governance#topic-6)[7. Read the cash timeline without mistaking closing cash for a cushion](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/monitoring-milestones-and-use-of-funds-in-corporate-venture-capital-evidence-for-investment-and-governance#topic-7)[8. Measure the pilot, then test its economic viability](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/monitoring-milestones-and-use-of-funds-in-corporate-venture-capital-evidence-for-investment-and-governance#topic-8)[9. Protect evidence quality and the right to disagree](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/monitoring-milestones-and-use-of-funds-in-corporate-venture-capital-evidence-for-investment-and-governance#topic-9)[10. Negotiate intellectual property before integration](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/monitoring-milestones-and-use-of-funds-in-corporate-venture-capital-evidence-for-investment-and-governance#topic-10)[11. Preserve commercial independence and address conflicts](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/monitoring-milestones-and-use-of-funds-in-corporate-venture-capital-evidence-for-investment-and-governance#topic-11)[12. Allocate roles and set a proportionate governance rhythm](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/monitoring-milestones-and-use-of-funds-in-corporate-venture-capital-evidence-for-investment-and-governance#topic-12)[13. Respond to adverse scenarios without renewing the bet through inertia](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/monitoring-milestones-and-use-of-funds-in-corporate-venture-capital-evidence-for-investment-and-governance#topic-13)[14. Correct monitoring errors without erasing the record](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/monitoring-milestones-and-use-of-funds-in-corporate-venture-capital-evidence-for-investment-and-governance#topic-14)[15. Respect each instrument's function and the limits of intermediation](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/monitoring-milestones-and-use-of-funds-in-corporate-venture-capital-evidence-for-investment-and-governance#topic-15)[16. Close each cycle with a decision that can be carried out](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/monitoring-milestones-and-use-of-funds-in-corporate-venture-capital-evidence-for-investment-and-governance#topic-16)[Frequently asked questions](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/monitoring-milestones-and-use-of-funds-in-corporate-venture-capital-evidence-for-investment-and-governance#faq)[References](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/monitoring-milestones-and-use-of-funds-in-corporate-venture-capital-evidence-for-investment-and-governance#references)

What you will find 

In corporate venture capital, or CVC, an investor seeks an economic return from an ownership stake and may also seek learning, access to technology or exposure to markets. These objectives can coexist, but they are not interchangeable. A solution may generate valuable knowledge for a corporation without supporting an independent business. A promising business may also fail to address a sponsoring unit's immediate priority. Monitoring should make those differences visible before enthusiasm for innovation takes the place of investment analysis.

01 

## Monitor to make decisions, not simply to receive reports

A useful milestone marks a verifiable change in a project's position: an integration works with authorized data, a customer pays for an accepted delivery, or a margin assumption holds up against actual costs. Meetings, presentations and demonstrations can show activity without establishing these outcomes. The central question is which decision each piece of evidence helps inform: continue, correct the approach, reduce exposure, purchase a service, consider further investment or stop an initiative. A report has limited value if nobody knows what decision its findings could change.

Tracking the use of funds connects these decisions to the company's financial capacity. Knowing the amount spent is insufficient; investors also need to understand what the spending helped discover, build or preserve. A planned expense may generate little information, while a small test may rule out an expensive assumption. Monitoring therefore needs to connect cash, deliverables and uncertainty. Its output is a reasoned decision that acknowledges evidence limitations and the costs of acting or waiting. Targets guide that process; they are not promises of profitability or recovery of capital.

02 

## Separate the financial investment thesis from the strategic hypothesis

A CVC thesis becomes easier to assess when it sets out two lines of reasoning. The financial thesis explains who buys, why they pay, what serving them costs and how the business might grow with sustainable economics. The strategic hypothesis identifies the corporation's problem, the internal knowledge needed to assess it and the outcome that would justify a commercial relationship. The connection needs evidence. An executive's interest does not establish market demand, and a persuasive sales presentation does not establish that a solution fits corporate operations.

Consider a startup developing software to reduce manual operational reconciliation. Its strategic hypothesis might involve reducing checking time and improving the handling of discrepancies within corporate units. Its financial hypothesis might be to sell a repeatable solution to businesses with similar processes, predictable implementation requirements and economically viable support. If every customer requires exclusive development, the corporation may still benefit while the scalability thesis weakens. Monitoring should expose this tension: a useful internal solution and a repeatable external business are related possibilities, not the same achievement.

For each hypothesis, record the evidence, the remaining gap, the responsible person and the decision affected. Interviews suggest a problem; signed contracts establish commercial obligations; receipts confirm cash inflows. None substitutes for the others. An investor may accept substantial uncertainty while identifying what remains unknown. Record meaningful disagreements too: technical specialists may see differentiation while the sales team sees obstacles to selling. Preserving both assessments helps reviewers distinguish a developing thesis from criteria quietly rewritten to accommodate weak results.

03 

## Give internal sponsorship verifiable responsibilities

An internal sponsor can open doors, explain priorities and help remove obstacles within the corporation. A name attached to a project, however, does not ensure staff availability, data access or a purchasing budget. Sponsorship should become operational commitments: who provides specialists, authorizes the pilot environment, takes responsibility for security and decides on a possible purchase. Those commitments need continuity through absences, reorganizations and changes in leadership. Otherwise, the startup may commit resources against support that exists only in informal conversations.

A workable arrangement distinguishes the executive sponsor who maintains the problem's relevance, the operational lead who follows execution and the buyer who controls the commercial process. These may be different people. An investment committee should not assume the sponsor can require procurement to buy. Nor should it count promised introductions to the corporation's customers as startup revenue. Access creates a conditional opportunity, subject to availability, consent, suitability and third-party interest. Any eventual customer still needs to make its own commercial decision.

Monitor sponsorship through commitments such as specialist hours actually provided, outstanding decisions and deadlines for required inputs. If a necessary dataset does not arrive, record that as a corporate dependency rather than automatically blaming the startup. The startup remains accountable for its own requirements. A replacement contact and a suspension rule can prevent continued spending through inertia. These arrangements also help distinguish a failed product test from a test that could not run because the agreed corporate inputs were unavailable.

04 

## Define milestones with acceptance criteria and consequences

Each milestone should combine an expected result, a measurement method, a time limit, an estimated cost and an acceptance owner. 'Complete the pilot' is inadequate because it may mean only that activities ended. A more informative criterion could require operation in two units for eight weeks, a defined reduction in weekly task time, minimum adoption and no unresolved critical security incident. The design should also identify conditions that make the evidence inconclusive, such as a material change in workload during measurement.

Milestones can follow a sequence that reduces uncertainty. First establish whether integration and controls allow a meaningful test. Next measure whether an operational benefit appears. Then investigate price, servicing costs and repeatability. This helps avoid funding commercial expansion before understanding implementation constraints. Some activities can overlap, but the choice should be explicit. Hiring a large team while integration remains uncertain increases the financial consequences of an untested assumption. A dependency map helps show which spending creates learning and which spending merely increases exposure.

Agree the consequences of acceptance before execution. Passing a technical test may permit the next stage without requiring the corporation to buy or the fund to invest again. Partial results might justify one retest with a defined budget and deadline. Negative results might end the pilot while leaving the ownership investment to be assessed under another thesis. If a funding tranche depends on milestones, the contract must define the condition and assessment process. An informal intention to provide more capital should not enter the startup's cash plan as available funding.

05 

## Turn the budget into a map of learning and cash

A budget that supports monitoring links expense categories to the capabilities required for milestones. Engineering may support reliability and integration; implementation enables operational testing; security reduces exposure and addresses requirements; commercial work tests willingness to pay. This does not mean each real produces a separately measurable result. It means investors can ask why a category grew, which delivery it protected and which hypothesis stopped being tested when funds moved elsewhere. The link between spending and purpose should remain understandable even when the plan changes.

Distinguish recognized expenses, commitments entered into and cash payments. An annual contract paid in installments can create an obligation larger than the month's payment. An issued invoice is not a receipt, and a planned hire is not necessarily a signed commitment. A useful view includes available cash, scheduled payments, conditional receivables and material obligations. Desired sales belong in separate scenarios. Otherwise, a projection may present financial survival as established even though it depends on winning business that does not yet exist.

Detail should match the decision. Reviewing every minor purchase may consume time without improving control, while overlooking a material infrastructure contract can conceal an obligation that is difficult to reduce. For significant expenses, record the supplier, purpose, milestone connection and any relationship with interested parties. Budget revisions should show where funds came from and where they went. Management retains room to execute while investors can identify changes that affect the thesis, cash duration or funding needs. Proportionate access to supporting documents remains important when an exception requires investigation.

06 

## A numerical example: keep equity, the pilot and the budget separate

Consider an entirely hypothetical startup with R$300,000 in cash. It receives a R$2 million equity investment at a pre-money valuation of R$8 million. The immediate post-money valuation is R$10 million, giving the new investor 20%, assuming a simple structure with no other instruments, adjustments or reserved interests affecting the calculation. That percentage represents ownership, not fixed remuneration or an automatic right to recover the investment. Its future value depends on business performance, negotiated rights, dilution and actual opportunities to sell the stake.

Separately, the corporation purchases a pilot for R$240,000, payable in two R$120,000 installments scheduled for months two and five. The investment finances the company; the pilot contract pays for specified commercial deliverables. Both may bring cash into the startup, but their classification and obligations differ. Pilot payments are not returns on the CVC ownership stake. The corporation makes one outlay to acquire ownership and another to obtain services, with separate reasons and approvals. Neither should be presented as evidence that the other has generated an economic return.

Planned cash outflows over twelve months total R$1.92 million: R$900,000 for engineering, R$420,000 for implementation, R$240,000 for security and infrastructure, R$240,000 for commercial activity and R$120,000 for administration. Pilot delivery costs are already included, avoiding double counting. To simplify the arithmetic, there are no other inflows, debt, distributions to owners or financial income, and all assumed outflows appear in this budget. Projected closing cash is R$620,000: R$300,000 plus R$2 million plus R$240,000, minus R$1.92 million. These are illustrative assumptions, not market benchmarks.

07 

## Read the cash timeline without mistaking closing cash for a cushion

In the same example, outflows are R$300,000 in the first quarter, R$480,000 in the second, R$540,000 in the third and R$600,000 in the fourth. Opening cash after the investment is R$2.3 million. Including the first pilot installment, the first quarter closes at R$2.12 million. The second closes at R$1.76 million, including the second installment. Subsequent balances are R$1.22 million and R$620,000. This timeline connects spending to milestones without mixing contracted commercial receipts with investment rounds that have not been agreed.

The R$620,000 balance does not provide indefinite financial room. If monthly outflows remained at R$200,000, the fourth-quarter average, it would cover approximately 3.1 months without further receipts. That division is hypothetical, not a survival forecast: commitments, seasonality and closure costs may change the outcome. Prepare monthly projections and, where cash movements are concentrated, weekly projections as well. A positive quarterly closing balance can conceal a shortage before an installment arrives. Available cash matters at the moment an obligation falls due, not only at the reporting boundary.

Now suppose the second R$120,000 installment moves from month five to month eight. Second-quarter closing cash becomes R$1.64 million, while the third quarter returns to R$1.22 million after receipt, with all other assumptions unchanged. Annual closing cash is unchanged, but exposure during the delay increases. If the installment is permanently lost, year-end cash falls to R$500,000 before any cost response. Report these events separately: delay changes the path of liquidity; permanent loss also changes the total available. Their remedies and implications for the commercial relationship can differ.

08 

## Measure the pilot, then test its economic viability

For the hypothetical pilot, two units have a combined baseline of 50 hours a week spent on the task. The operational criterion is a reduction of at least 30%, to 35 hours or less, across eight weeks of comparable observation. It also requires use in at least 80% of eligible cases and no unresolved critical security incident. Suppose measurement finds 34 hours and 84% adoption, with the controls satisfied. The observed reduction is 16 hours, or 32%, within the sample's conditions and limitations.

Operational acceptance does not complete the economic analysis. Hypothetically valuing each hour at R$100 and using 48 operating weeks a year gives R$76,800 in annual released capacity across the two units. That is not necessarily a cash saving: staff may be reassigned without reducing expenditure. Quality and turnaround improvements may add benefits, but they require their own evidence. Avoid overlapping benefits or assigning financial value to improvements nobody measured. A more available team and a smaller payroll are different outcomes, even when both discussions begin with hours saved.

Consider a future proposal covering six units: a R$180,000 annual subscription plus R$60,000 for implementation. If every pair of units reproduced the reduction, the benefit would be 48 hours weekly, valued at R$230,400 annually under the same convention. Subtracting the subscription leaves R$50,400; including implementation produces a first-year deficit of R$9,600. The R$240,000 pilot already paid for remains a separate experimentation cost. Expansion still requires testing comparability, incremental benefit and omitted costs. Success in two units does not establish that six units will achieve identical adoption or savings.

09 

## Protect evidence quality and the right to disagree

Precise-looking metrics can support weak conclusions. The reported time reduction would be questionable if case volume fell, difficult cases moved to another team or work continued outside the recorded process. Define the denominator, exclusions and data sources before the pilot. Track errors, rework and supervisory time too: reducing the main task while increasing a supporting task may simply move costs. Comparable observation requires more than using the same metric name. Reviewers need to understand whether the work measured before and after was substantively equivalent.

The evidence package should allow reviewers to reconstruct the reasoning without exposing unnecessary information. It may include methodology, aggregated records, operational acceptance, protected samples and explanations of exceptions. Startup-produced evidence is not automatically invalid, but its incentives matter. Corporate specialist validation can also be biased, particularly when the specialist's unit sponsors the project. For material decisions, review by someone without direct responsibility for the outcome can reveal weaknesses in measurement and interpretation. Appropriate access restrictions should still protect personal information, confidential operations and third-party business information.

When people disagree, the minutes should separate accepted data from contested interpretation. Operations may acknowledge fewer hours while rejecting the estimate of cash savings; an investor may accept pilot results while finding external demand unproven. Identify what information would resolve the disagreement and what obtaining it would cost. Not every dispute warrants another test. If additional evidence would not change the decision, or costs more than its expected value, ending the analysis with an explicit uncertainty may be reasonable. Agreement should not be manufactured by deleting a defensible minority assessment.

10 

## Negotiate intellectual property before integration

Corporate collaboration can involve pre-existing software, third-party components, data, documentation and improvements created during the pilot. Contracts should distinguish these before teams begin working together. Paying for a pilot does not automatically determine ownership of everything developed. A license may give the corporation sufficient use rights without transferring the startup's core technology; a specific commissioned deliverable may require different treatment. The appropriate arrangement depends on the subject matter, each party's contribution and applicable legal analysis. Technical access and legal permission should both be understood before integration proceeds.

For the investor, excessively broad terms can damage the asset supporting the ownership investment. If the corporation receives exclusivity over every improvement related to its industry, the startup may lose customers, fundraising options and freedom to develop its product. The corporation also needs to protect its own information, integrations and materials. Negotiations should identify what each party retains, what can be reused and which permissions are required. Libraries and other dependencies require license checks. A commercially attractive pilot can create future constraints if these commitments are left unresolved.

Monitoring should follow the chain of rights: developer agreements, usage permissions, dependencies and commitments in customer contracts. A technical milestone is incomplete when the product works but commercial exploitation depends on missing permission. For personal or confidential data, ownership of technology does not replace purpose limitations, access controls or protection obligations under the applicable Brazilian framework. Private documents should not be placed on public blockchains. An integrity record may help detect alteration; it does not establish legitimate authorship, legal title or truth, nor does blockchain establish reserve solvency or guarantee payment.

11 

## Preserve commercial independence and address conflicts

Commercial independence supports the startup's ability to serve other customers, potentially including the investor's competitors, within legitimate contractual limits. A restriction may have a specific justification, but its scope, duration and consideration should be clear. Broad, uncompensated exclusivity can turn investment into dependency. The cost includes lost sales and difficulty demonstrating a market, negotiating with future investors or building a product for multiple organizations. Review restrictions in terms of their practical consequences, rather than assuming the investment itself adequately compensates the company for every commercial limitation.

Conflicts arise when the corporation wants discounted prices and development priority while the startup needs margins and room to serve its market. An investor representative should not use governance information to advantage a procurement negotiation without appropriate conflict handling. Separate contacts where useful and record when someone should abstain. Similar care applies to competing customers' information: shareholder information rights are not unrestricted access to third-party trade secrets. Governance needs enough information for oversight while respecting confidentiality and the boundaries of the representative's role.

Concentration indicators make dependency measurable. Look beyond the corporate group's share of revenue to engineering hours, outstanding payments and exclusive functionality. Revenue may be diversified while nearly the entire team works for the investor. If a corporate contract funds adaptations with little reuse value, assess its commercial benefit separately from product development. Responses might include specific pricing, an effort limit or revised scope that preserves capacity for independent customers. These choices involve trade-offs: reducing dependency may also reduce near-term revenue or require a difficult renegotiation.

12 

## Allocate roles and set a proportionate governance rhythm

Startup management is responsible for execution and information quality. The corporate sponsor owns the internal dependencies it accepted. Specialists assess integration, operations, security and other matters within their competence. Procurement decides through the commercial process, while the investment committee assesses ownership exposure and potential further funding. This division prevents the committee from becoming an operational help desk and the sponsor from promising decisions outside its authority. Specific contractual rights still apply, including matters requiring consent. Clear roles do not remove the need to escalate material issues to the appropriate decision-maker.

A proportionate routine may combine monthly cash and risk reviews with assessments at significant milestones. Recurring reports should emphasize changes since the previous version instead of repeating a corporate presentation. Useful content includes current and projected cash, actual spending against budget, material commitments, milestone progress, evidence quality and requested decisions. Management should explain the cause, impact and response for each material deviation. Investors can then focus on exceptions capable of changing the thesis or execution capacity, rather than treating every operational variation as a committee-level issue.

Governance itself costs money and attention. Separate reports for multiple corporate teams can consume the staff needed to deliver the product. A shared package with suitable permissions and stable definitions reduces duplication. Operational issues can have owners and deadlines outside the committee, while investment decisions are recorded in the authorized forum. Disclose remuneration arrangements for assessors, consultants and managers when they may influence recommendations. Specialists can improve analysis without eliminating responsibility, conflicts or error. Reporting effort should be assessed by the decisions it improves, not by the volume of documents produced.

13 

## Respond to adverse scenarios without renewing the bet through inertia

Suppose the second pilot installment is permanently lost and an additional R$180,000 security requirement arises. With other assumptions unchanged, projected closing cash falls from R$620,000 to R$320,000: R$120,000 less in receipts and R$180,000 more in outflows. Deferring R$150,000 of commercial spending that has not been committed would increase the projected balance to R$470,000. The arithmetic is straightforward; the decision is not. Deferral preserves cash while potentially delaying proof of independent demand. Existing commitments must be distinguished from expenses management can actually postpone.

Another scenario involves replacing the sponsor after the technology has demonstrated results. This does not automatically invalidate technical evidence, but it may remove the route to a corporate purchase. Reclassify the risk, identify someone with legitimate authority and limit the waiting period. The startup should not retain a dedicated team indefinitely because somebody might revive the project. If other customers offer alternatives, redirection must consider rights over completed work and adaptation costs. The investor's influence may help clarify the situation, but it does not establish a replacement buyer or budget.

Negative results need explicit decision triggers. A critical security incident may suspend use until properly addressed; excessive implementation costs may prevent expansion; lack of external demand may weaken the equity thesis. Additional capital requires a plan explaining the uncertainty it would address and the alternatives considered. An earlier investment does not make the next one obligatory. Stopping an initiative, reducing operations or recognizing a loss may preserve remaining resources without ensuring investment recovery or removing existing obligations. Decisions should address the current evidence rather than the desire to justify money already spent.

14 

## Correct monitoring errors without erasing the record

A common mistake is treating a commercial contract as sufficient evidence of investment quality. The corporation may buy because of a specific need, sponsor influence or an innovation budget without demonstrating repeatable demand. Separate investor-group revenue, special terms and evidence from other customers. Another mistake turns targets into achievements: a proposal becomes a sale, a test environment becomes implementation and pilot approval becomes a recurring contract. Define each stage and require its corresponding evidence. Movement through one stage should not silently claim that the next stage has already occurred.

An approved budget is also not proof of effective control. A startup may stay within its total while quietly abandoning the test that justified the investment. Read financial performance alongside milestone progress. Conversely, exceeding one category does not prove poor management if a change was justified, authorized where necessary and consistent with available cash. The purpose is to identify decisions and consequences, including estimation errors, changed circumstances, weak execution or possible misuse. Treating every variance alike can hide the difference between a reasoned adaptation and a material failure of oversight.

When a metric is wrong, retain the earlier version, explain the cause and revisit affected decisions. If the example's 34 weekly hours excluded necessary supervision, revise the benefit before relying on it for expansion. A correction plan should identify an owner, deadline and validation method. Omitted information, undeclared conflicts and inconsistent documents may require proportionate investigation. Willingness to correct supports governance but does not replace verification or make every failure acceptable. A traceable record also helps reviewers distinguish an honest recalculation from selective removal of inconvenient evidence.

15 

## Respect each instrument's function and the limits of intermediation

Equity, loans and commercial contracts create different rights and risks. Ownership follows corporate rights and business risk; debt establishes payment obligations under its terms; a pilot pays for a defined service. A convertible requires analysis of its specified events, rights and conversion criteria. Existing eligible receivables differ from hoped-for sales. A donation to a nonprofit is neither equity nor a promise of financial return. Monitoring should distinguish these instruments when one relationship includes several. Similar-looking cash inflows can carry very different obligations, enforcement possibilities and exposure to loss.

The Brazilian company's legal form matters too. A business cannot admit equity partners while remaining a MEI, Brazil's individual microentrepreneur category; an appropriate structural change must precede an incompatible ownership arrangement. Public securities distribution and regulated financial activities require suitable legal structures and participants. Technology or a CNAE economic activity classification is not authorization. Banco Central, CVM, Portal do Empreendedor and ANPD materials are reference entry points for relevant questions, not substitutes for case-specific analysis or proof that KEZS is authorized to conduct a regulated activity.

KEZS connects entrepreneurial projects and potential funders through technology and intermediation. A project-based method can organize theses, milestones, documents and funding needs to support comparison and diligence; this describes potential methodological usefulness, not verified availability of particular features. KEZS does not assign a credit score. Organized documentation does not establish approval, repayment, profitability, liquidity or capital protection. Investors remain responsible for their diligence and decisions. Assess any recording technology by its actual function without inferring unverified operational capability, regulatory permission or financial protection from the presence of software or records.

16 

## Close each cycle with a decision that can be carried out

Each review cycle should produce an actionable, reviewable decision. For every milestone, record the result, accepted evidence, limitations and consequence. In the example, reviewers could accept that the pilot met operational criteria while postponing expansion because estimated first-year benefit is below subscription and implementation costs. There is no contradiction: technical and economic viability answer different questions. The next step might investigate additional verifiable benefits or renegotiate scope and price. Keep the original test intact rather than changing its criteria retrospectively to make the commercial case appear stronger.

Before further investment, the committee should examine remaining cash, commitments and the hypothesis that additional capital would fund. Can the startup develop independent customers, preserve technology rights and reduce implementation costs? Alternatives should include continuing without further investment, revising the plan and stopping a particular activity. Compare them using explicit assumptions, potential loss, opportunity cost, dilution and future funding needs. A successful pilot guarantees neither a higher company value nor a buyer for the stake. Additional funding can extend learning while also increasing exposure to an unresolved business model.

A practical close combines an updated financial projection, milestone records, relevant contracts, open risks and named owners for upcoming decisions. Another reviewer should be able to understand why the project continued, changed or stopped. Quality depends on coherence between thesis, evidence, resources and decision. More indicators rarely repair a missing connection between them. The investor's task is to require enough information to act under uncertainty while acknowledging possible error. Neither the startup nor its sponsor can turn that process into an assured return, and monitoring does not create such an assurance.

FAQ 

## Frequently asked questions.

### Should a successful pilot automatically release another investment?

Only a valid contractual obligation with conditions actually satisfied could require funding, and its interpretation needs separate analysis. As an investment decision, pilot success provides specific evidence: it may establish integration and operational benefit without proving sustainable pricing, independent demand or scalability. The committee should compare results with the equity thesis and assess the capital needed to address remaining gaps. Passing a commercial or technical stage should not create an ambiguous promise of further investment. Keep the pilot acceptance decision distinct from any separately negotiated funding condition.

### How should revenue paid by the corporate investor be treated?

Identify the relationship, contracted service, pricing terms, acceptance requirements and actual receipt. It is relevant commercial revenue when it reflects the company's operations, but it does not establish external demand. Examine concentration, margin and dependence on special treatment. For the equity assessment, payments for purchased services remain separate from dividends or proceeds from selling the stake. Mixing these flows can make corporate expenditure appear to be a CVC return. Also check whether delivery consumes resources the startup needs to serve independent customers.

### What if the internal sponsor loses priority or leaves the role?

Identify which commitments remain valid and who has authority to take responsibility for them. Reassess dependencies, costs and the permitted waiting period. Existing technical evidence may remain useful even as the likelihood of a purchase changes. Without a replacement and a concrete plan, the startup should avoid expanding costs solely on expectation. Investors can help reorganize the relationship without presenting influence as a purchasing guarantee or pressuring teams to approve an unjustified contract. A suspension or redirection decision may be more defensible than indefinite waiting.

### How much detail is appropriate when monitoring the use of funds?

Provide enough detail to identify deviations affecting cash, milestones or the thesis, with attention to material commitments and related parties. Consistent categories, monthly projections and explanations of major variances are often more useful than hundreds of receipts without context. Supporting documents should be accessible under applicable rights and permissions. A small expense can still indicate a conflict or irregularity, so financial size alone does not settle the matter. Assess value, nature and potential decision impact while avoiding reporting demands that consume disproportionate execution capacity.

### Does the corporation need to own technology developed during the pilot?

Ownership does not follow automatically from sponsorship or payment. Distinguish pre-existing technology, specific deliverables, third-party components and reusable improvements. A license may provide the required usage rights without removing the startup's main asset. If transfer or exclusivity is proposed, assess its effect on sales, company value and future fundraising. Security, confidentiality and data protection require their own provisions even when intellectual property ownership is clear. The monitoring record should also verify that developers and other contributors have granted the rights necessary for the agreed arrangement.

### What is KEZS's role in assessing project milestones?

KEZS connects entrepreneurial projects and potential funders through technology and intermediation. Transparent document organization can help investors locate assumptions, distinguish stages and formulate diligence questions. This methodological usefulness neither establishes particular operational features nor automatically validates project information. KEZS does not assign a credit score. Investors and other responsible participants retain their roles in verifying documents, assessing instruments and risks, and making decisions. A well-organized record can make a gap easier to identify; it does not supply missing evidence or provide a financial guarantee.

### When does an inconclusive result justify repeating a test?

A retest is useful when an identifiable cause explains the inconclusive outcome, a feasible change can address it and a decision depends on the resulting information. Set cost, duration and stopping criteria before restarting. Repeating tests indefinitely until a favorable metric appears selects results rather than evaluating them. If fragmented data or unstable integration reflects a customer's normal conditions, that difficulty is also evidence about product cost and feasibility. The committee should consider it rather than artificially removing it from the assessment.

### Does milestone monitoring reduce the risk of losing capital?

Monitoring can reveal problems earlier and improve decisions about spending, corrections and further investment. It does not eliminate execution failures, market changes, conflicts, dilution or the absence of buyers for an ownership stake. It also costs resources and may fail when evidence is weak or decision-makers avoid acting. Its usefulness lies in clarifying risks and choices, including the choice not to increase exposure. A monitoring dashboard provides no guarantee of repayment, profitability or liquidity, and losses remain possible even when reporting is careful and decisions are documented.

## References and context

Institutional reference points for checking applicable rules and guidance. Calculations and scenarios are original examples, not quotes, historical results or individualized recommendations.
- [Banco Central — correspondentes no País ↗](https://www.bcb.gov.br/estabilidadefinanceira/exibenormativo?tipo=Resolu%C3%A7%C3%A3o%20CMN&numero=4935)
- [CVM — Resolução 88, texto e alterações ↗](https://conteudo.cvm.gov.br/legislacao/resolucoes/resol088.html)
- [CVM — Resolução 175, fundos de investimento ↗](https://conteudo.cvm.gov.br/legislacao/resolucoes/resol175.html)
- [Portal do Empreendedor — perguntas sobre MEI ↗](https://www.gov.br/empresas-e-negocios/pt-br/empreendedor/perguntas-frequentes)
- [ANPD — orientações e perguntas frequentes ↗](https://www.gov.br/anpd/pt-br/acesso-a-informacao/perguntas-frequentes)

AI-assisted educational content. Decisions require verification of the information, instruments and providers in each actual case.

## Keep learning.[Explore the category ↗](https://kezs.com.br/en/learn/corporate-venture-capital-diligence)

[

Corporate Venture Capital: diligence and governance 

### Data Rooms and Evidence Quality for Corporate Venture Capital

How corporate venture investors can assess evidence, internal sponsorship and intellectual property while separating pilot results from equity returns.Explore the article ↗  ](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/data-rooms-and-evidence-quality-for-corporate-venture-capital)

[

Corporate Venture Capital: diligence and governance 

### Cash, Revenue and Execution Capacity in Corporate Venture Capital

Assess cash, revenue and execution in corporate venture capital through pilot economics, internal sponsorship, governance and commercial independence.Explore the article ↗  ](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/cash-revenue-and-execution-capacity-in-corporate-venture-capital)

[

Corporate Venture Capital: diligence and governance 

### Contracts, Investor Powers and Rights in Corporate Venture Capital

Understand corporate venture capital contracts, investor rights, internal sponsorship, intellectual property and commercial independence in Brazil.Explore the article ↗  ](https://kezs.com.br/en/learn/corporate-venture-capital-diligence/contracts-investor-powers-and-rights-in-corporate-venture-capital)

From knowledge to decisions 

## Plan your next step with more clarity.[Get started ↗](https://kezs.net/?lang=en)